Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and nitric oxide (NO) are a group of highly reactive, oxygen- and nitrogen-containing molecules that serve as critical regulators of cellular physiology [Sies et al., 2017]. In healthy tissues, they function as secondary messengers in signal transduction pathways, regulating processes such as vasodilation, immune response, and gene expression [StatPearls, 2023]. However, an imbalance between their production and the body's antioxidant defenses leads to oxidative and nitrosative stress, which causes damage to DNA, proteins, and lipids [Pizzino et al., 2017]. This damage is a hallmark of various pathologies, including cardiovascular diseases, neurodegeneration, and cancer. Therapeutic strategies involve the use of antioxidants and scavengers to neutralize excess ROS/NO or the use of donors to restore signaling in conditions like endothelial dysfunction [PubChem]. Because these molecules are ubiquitous and essential for normal function, pharmacological intervention requires precise targeting to avoid disrupting homeostatic signaling.
Drugs targeting these species typically act as scavengers to neutralize reactive intermediates, as donors to supplement levels (e.g., NO donors), or as inhibitors of the enzymes responsible for their production (e.g., NADPH oxidase or Nitric oxide synthase inhibitors) [Pizzino et al., 2017].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and nitric oxide (ROS/NO).